rs55716016

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The NM_022356.4(P3H1):​c.139G>T​(p.Ala47Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0327 in 1,604,686 control chromosomes in the GnomAD database, including 1,076 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A47A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.041 ( 193 hom., cov: 33)
Exomes 𝑓: 0.032 ( 883 hom. )

Consequence

P3H1
NM_022356.4 missense

Scores

1
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5

Conservation

PhyloP100: 0.206

Publications

8 publications found
Variant links:
Genes affected
P3H1 (HGNC:19316): (prolyl 3-hydroxylase 1) This gene encodes an enzyme that is a member of the collagen prolyl hydroxylase family. These enzymes are localized to the endoplasmic reticulum and their activity is required for proper collagen synthesis and assembly. Mutations in this gene are associated with osteogenesis imperfecta type VIII. Three alternatively spliced transcript variants encoding different isoforms have been described. Other variants may exist, but their biological validity has not been determined. [provided by RefSeq, Aug 2011]
P3H1 Gene-Disease associations (from GenCC):
  • osteogenesis imperfecta type 8
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • osteogenesis imperfecta type 2
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • osteogenesis imperfecta type 3
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0025526285).
BP6
Variant 1-42766833-C-A is Benign according to our data. Variant chr1-42766833-C-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 379443.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0735 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
P3H1NM_022356.4 linkc.139G>T p.Ala47Ser missense_variant Exon 1 of 15 ENST00000296388.10 NP_071751.3 Q32P28-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
P3H1ENST00000296388.10 linkc.139G>T p.Ala47Ser missense_variant Exon 1 of 15 1 NM_022356.4 ENSP00000296388.5 Q32P28-1

Frequencies

GnomAD3 genomes
AF:
0.0414
AC:
6297
AN:
152182
Hom.:
192
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0756
Gnomad AMI
AF:
0.0844
Gnomad AMR
AF:
0.0249
Gnomad ASJ
AF:
0.0389
Gnomad EAS
AF:
0.00116
Gnomad SAS
AF:
0.0437
Gnomad FIN
AF:
0.0210
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.0296
Gnomad OTH
AF:
0.0521
GnomAD2 exomes
AF:
0.0311
AC:
7174
AN:
230808
AF XY:
0.0320
show subpopulations
Gnomad AFR exome
AF:
0.0806
Gnomad AMR exome
AF:
0.0216
Gnomad ASJ exome
AF:
0.0392
Gnomad EAS exome
AF:
0.00181
Gnomad FIN exome
AF:
0.0179
Gnomad NFE exome
AF:
0.0295
Gnomad OTH exome
AF:
0.0320
GnomAD4 exome
AF:
0.0318
AC:
46129
AN:
1452386
Hom.:
883
Cov.:
32
AF XY:
0.0320
AC XY:
23119
AN XY:
722992
show subpopulations
African (AFR)
AF:
0.0836
AC:
2796
AN:
33464
American (AMR)
AF:
0.0234
AC:
1045
AN:
44688
Ashkenazi Jewish (ASJ)
AF:
0.0391
AC:
1021
AN:
26098
East Asian (EAS)
AF:
0.000781
AC:
31
AN:
39684
South Asian (SAS)
AF:
0.0442
AC:
3811
AN:
86244
European-Finnish (FIN)
AF:
0.0178
AC:
792
AN:
44430
Middle Eastern (MID)
AF:
0.0411
AC:
237
AN:
5768
European-Non Finnish (NFE)
AF:
0.0310
AC:
34471
AN:
1111718
Other (OTH)
AF:
0.0319
AC:
1925
AN:
60292
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
3124
6249
9373
12498
15622
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1346
2692
4038
5384
6730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0414
AC:
6309
AN:
152300
Hom.:
193
Cov.:
33
AF XY:
0.0408
AC XY:
3035
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.0757
AC:
3146
AN:
41570
American (AMR)
AF:
0.0249
AC:
381
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0389
AC:
135
AN:
3468
East Asian (EAS)
AF:
0.00116
AC:
6
AN:
5176
South Asian (SAS)
AF:
0.0439
AC:
212
AN:
4828
European-Finnish (FIN)
AF:
0.0210
AC:
223
AN:
10616
Middle Eastern (MID)
AF:
0.0374
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
0.0296
AC:
2010
AN:
68012
Other (OTH)
AF:
0.0510
AC:
108
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
312
623
935
1246
1558
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0319
Hom.:
292
Bravo
AF:
0.0432
TwinsUK
AF:
0.0310
AC:
115
ALSPAC
AF:
0.0358
AC:
138
ESP6500AA
AF:
0.0676
AC:
276
ESP6500EA
AF:
0.0297
AC:
243
ExAC
AF:
0.0306
AC:
3643
Asia WGS
AF:
0.0190
AC:
67
AN:
3478
EpiCase
AF:
0.0357
EpiControl
AF:
0.0339

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Osteogenesis imperfecta type 8 Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 06, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Osteogenesis Imperfecta, Recessive Uncertain:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

not specified Benign:1
May 06, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Osteogenesis imperfecta Benign:1
Jul 14, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
19
DANN
Benign
0.94
DEOGEN2
Benign
0.064
.;.;T;.
Eigen
Benign
-0.49
Eigen_PC
Benign
-0.31
FATHMM_MKL
Benign
0.19
N
LIST_S2
Benign
0.57
T;T;T;T
MetaRNN
Benign
0.0026
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.1
L;L;L;.
PhyloP100
0.21
PrimateAI
Pathogenic
0.83
D
PROVEAN
Benign
-0.34
N;N;N;N
REVEL
Benign
0.014
Sift
Benign
0.39
T;T;T;T
Sift4G
Benign
0.38
T;T;T;.
Polyphen
0.047, 0.0080
.;B;B;B
Vest4
0.090
MPC
0.94
ClinPred
0.019
T
GERP RS
3.2
PromoterAI
0.018
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.2
Varity_R
0.052
gMVP
0.52
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs55716016; hg19: chr1-43232504; API